sdbn.org

News, Syndication, Xconomy »

SD Life Sciences Roundup: Gen-Probe, Zogenix, & the Innovation Economy
Posted by sandiegobiotech May 3rd, 2012 .
No Comments

Here’s our wrap-up of life sciences news over the past week, along with some life sciences data from the latest Connect Innovation Report. —Bedford, MA-based Hologic (NASDAQ: HOLX) agreed to pay $3.7...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill?
Posted by sandiegobiotech May 3rd, 2012 .
No Comments

A recent meeting focused on “Reinventing Biotech’s Business Model” provided an interesting window into the spectrum of approaches being used to create new biotech companies. Unfortunately, it did...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

5 Things to Do Before the New Patent Law Takes Full Effect
Posted by sandiegobiotech May 2nd, 2012 .
No Comments

On September 16, 2011, President Obama signed into law the America Invents Act, the most important modification to U.S. patent law in 60 years—and some even argue, since 1836. Some changes went into...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Innovation Report Shows San Diego Added 695 Tech Jobs at End of 2011
Posted by sandiegobiotech May 1st, 2012 .
No Comments

San Diego’s innovation economy added 75 new technology companies and 695 jobs during the last three months of 2011, according to the Connect Innovation Report for the fourth quarter of 2011. New jobs...

[[Click headline to continue reading.]] More...

Diagnostics, News, Syndication, Xconomy »

Hologic Buys Gen-Probe for $3.7B, Making Molecular Diagnostics Push
Posted by sandiegobiotech April 30th, 2012 .
No Comments

Hologic has made big-money acquisitions before, and today it’s making another sizable one. The Bedford, MA-based maker of women’s health products (NASDAQ: HOLX) said today it has agreed to purchase...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Biotech IPOs Start to Show Some Modest Signs of Life
Posted by sandiegobiotech April 30th, 2012 .
No Comments

[Updated: 2:10 pm ET, 5/2/12] Something feels wrong about putting the words “biotech” and “IPO” together in a headline. This market has been lifeless for so long that few investors even play the game...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Taking Open Biology to the Next Level: Notes from the Sage Congress
Posted by sandiegobiotech April 27th, 2012 .
No Comments

Last week, attendees of Sage Bionetworks’ 3rd Annual Congress came to San Francisco with the bold charge to speed up drug discovery and ready to stand on the shoulders of the previous two Congresses...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

SD Life Sciences Roundup: Amylin, Illumina, AstraZeneca Acquires Ardea, & More
Posted by sandiegobiotech April 27th, 2012 .
No Comments

Some big changes are underway in San Diego, with AstraZeneca’s big buyout of Ardea Biosciences and Illumina’s ambitious bid to develop an app store. There’s big biology and big data happening too....

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Illumina Opens Apple-Inspired App Store for DNA Software Developers
Posted by sandiegobiotech April 25th, 2012 .
No Comments

San Diego-based Illumina has talked openly about how it is inspired by the way Apple integrates hardware and software, and now it’s taking another cue from the consumer technology colossus. Illumina,...

[[Click headline to continue reading.]] More...

Drug Development, News, Syndication, Xconomy »

AstraZeneca Reloads its Pipeline with Ardea Deal, Could be Still Hunting
Posted by sandiegobiotech April 23rd, 2012 .
No Comments

AstraZeneca (NYSE: AZN), the global pharmaceutical giant based in London, is replenishing its drug pipeline with its acquisition of San Diego’s Ardea Biosciences (NASDAQ: RDEA), which was disclosed...

[[Click headline to continue reading.]] More...